The Journal of Pediatrics
Volume 149, Issue 3 , Pages 320-323 , September 2006

Coronary artery calcification, serum lipids, lipoproteins, and peripheral inflammatory markers in adolescents and young adults with type 1 diabetes

Presented in part at the ESPE/LWPES 7th Joint Pediatric Endocrine Meeting, Lyon, France, September 2005.

Received 21 December 2005 ,Revised 24 March 2006 ,Accepted 24 April 2006.

References 

  1. Kannel WB, McGee DL. Diabetes and cardiovascular disease (the Framingham Study). JAMA. 1979;241:2035–2038
  2. Whiteley L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease risk equivalent?. Diabetes Care. 2005;28:1588–1593
  3. Parikh A, Sochett EB, McCrindle BW, Dipchand A, Daneman A, Daneman D. Carotid distensibility and cardiac function in adolescents with type 1 diabetes. J Pediatr. 2000;137:465–469
  4. Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Diabetes Care. 1998;21:1004–1007
  5. Krantz JS, Mack WJ, Hodis HN, Liu C-R, Liu C-H, Kaufman FR. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr. 2004;145:452–457
  6. Gunczler P, Lanes R, Lopez E, Esaa S, Villaroel O, Revel-Chon R. Cardiac mass and function, carotid artery intima-media thickness and lipoprotein (a) levels in children and adolescents with type 1 diabetes mellitus of short duration. J Pediatr Endocrinol Metab. 2002;15:181–186
  7. Verges BL. Dyslipidemia in diabetes mellitus (review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis). Diabetes Metab. 1999;25(suppl 3):32–40
  8. Deveraj S, O’Keefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metab. 2005;90:4549–4554
  9. Jialal I, Devaraj S, Venugopal SK. C-reactive protein (risk marker or mediator in atherothrombosis?). Hypertension. 2004;44:6
  10. Detrano RC, Doherty TM, Davis MJ, Stary HC. Predicting coronary events with coronary calcium (pathophysiologic and clinical problems). Curr Probl Cardiol. 2000;25:374–402
  11. Meigs JB, Larson MG, D’Agostino RB, Levy D, Clouse ME, Nathan DM, et al. Coronary artery calcification in type 2 diabetes and insulin resistance (the Framingham offspring study). Diabetes Care. 2002;25:1313–1319
  12. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, et al. Effect of type 1 diabetes on the gender difference in coronary artery calcification: role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACT1) Study. Diabetes. 2003;52:2833–2839
  13. Starkman HS, Cable G, Ala V, Hecht H, Donnelly CM. Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care. 2003;26:433–436
  14. Freedman DS, Srinivasan SR, Shear CL, Franklin FA, Webber LS, Behrenson GS. The relation of apolipoproteins A-1 and B in children to parental myocardial infarction. N Engl J Med. 1986;315:721–727
  15. Jialal I, Devaraj S, Venugopal SK. C-reactive protein (risk marker or mediator in atherothrombosis?). Hypertension. 2004;44:6–11
  16. Roombereger JA, Brundage BH, Rader DJ, Condos G. Electron beam computed tomographic coronary calcium scanning (a review and guidelines for use in asymptomatic persons). Mayo Clin Proc. 1999;74:243–252
  17. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832
  18. Tsuchiya M, Suzuki E, Egawa K, Nishio H, Inoue S, Mitsunami K, et al. Stiffness and impaired blood flow in lower-leg arteries are associated with severity of coronary artery calcification among asymptomatic type 2 diabetic patients. Diabetes Care. 2004;27:2409–2415
  19. Tayebjee MH, Lim HS, MacFadyen RJ, Lip GYH. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase−1 and −2 in type 2 diabetes (effect of 1 year’s cardiovascular risk reduction therapy). Diabetes Care. 2005;27:2049–2051
  20. Maahs DM, Maniatis AK, Nadeau K, Wadwa P, McFann K, Klingensmith GJ. Total cholesterol and high-density lipoprotein levels in pediatric subjects with type 1 diabetes mellitus. J Pediatr. 2005;147:544–546
  21. Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes. Diabetes Care. 2005;28:1965–1973
  22. Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653

PII: S0022-3476(06)00379-9

doi: 10.1016/j.jpeds.2006.04.064

The Journal of Pediatrics
Volume 149, Issue 3 , Pages 320-323 , September 2006

Article Tools